The clinical trials landscape is undergoing a fundamental transformation. Traditional, paper-based processes are giving way to digital systems that promise greater efficiency, broader patient reach, and faster decision-making. But as trials go digital, a new imperative has emerged: ensuring that innovation doesn’t come at the cost of inclusivity.